Related Experiment Video
Updated: Nov 2, 2025
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
Identification of COVID-19 B-cell epitopes with phage-displayed peptide library
Jing-You Guo1,2, I-Ju Liu2, Hsiu-Ting Lin2
1Institute of Biologic Chemistry, Academia Sinica, Taipei, Taiwan.
Insights
Researchers identified key B-cell epitopes on the SARS-CoV-2 virus. These findings are crucial for developing new diagnostic tools and vaccines to combat Coronavirus disease 19 (COVID-19).
Area of Science:
- Virology
- Immunology
- Vaccine Development
Background:
- Coronavirus disease 19 (COVID-19), caused by SARS-CoV-2, has led to millions of deaths globally.
- Effective diagnostic tools and vaccines are essential to control the spread of COVID-19.
- Identifying viral epitopes is critical for developing these medical countermeasures.
Purpose of the Study:
- To identify specific B-cell epitopes on the SARS-CoV-2 virus.
- To find epitopes that mimic natural viral structures.
- To aid in the development of COVID-19 diagnostics and vaccines.
Main Methods:
- Phage display technology was used to identify antibody targets in COVID-19 patient sera.
- Enzyme-linked immunosorbent assays (ELISAs) were employed for antibody binding assessment.
- Bioinformatic tools (VaxiJen, BepiPred-2.0, DiscoTope 2.0) and protein structural analysis (PyMOL) were utilized for epitope prediction and analysis.
Main Results:
- Biopanning identified 36 enriched peptides from two COVID-19 patients.
- Four consensus motifs were found, corresponding to two potential B-cell epitopes on SARS-CoV-2 proteins.
- Synthesized peptides were validated for antibody binding and serological detection.
Conclusions:
- The identified B-cell epitopes on SARS-CoV-2 are valuable for understanding COVID-19 pathogenesis.
- These epitopes can facilitate the development of novel epitope-based serological diagnostic assays.
- The findings support the creation of targeted vaccines against SARS-CoV-2.
Background:
Coronavirus disease 19 (COVID-19) first appeared in the city of Wuhan, in the Hubei province of China. Since its emergence, the COVID-19-causing virus, SARS-CoV-2, has been rapidly transmitted around the globe, overwhelming the medical care systems in many countries and leading to more than 3.3 million deaths. Identification of immunological epitopes on the virus would be highly useful for the development of diagnostic tools and vaccines that will be critical to limiting further spread of COVID-19.
Methods:
To find disease-specific B-cell epitopes that correspond to or mimic natural epitopes, we used phage display technology to determine the targets of specific antibodies present in the sera of immune-responsive COVID-19 patients. Enzyme-linked immunosorbent assays were further applied to assess competitive antibody binding and serological detection. VaxiJen, BepiPred-2.0 and DiscoTope 2.0 were utilized for B-cell epitope prediction. PyMOL was used for protein structural analysis.
Results:
36 enriched peptides were identified by biopanning with antibodies from two COVID-19 patients; the peptides 4 motifs with consensus residues corresponding to two potential B-cell epitopes on SARS-CoV-2 viral proteins. The putative epitopes and hit peptides were then synthesized for validation by competitive antibody binding and serological detection.
Conclusions:
The identified B-cell epitopes on SARS-CoV-2 may aid investigations into COVID-19 pathogenesis and facilitate the development of epitope-based serological diagnostics and vaccines.
More Related Videos
07:32Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
Published on: September 30, 2019
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020